Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes and mental health: a Two-Year study to personalize care

NCT ID NCT05548699

Knowledge-focused Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study followed 1,290 adults with type 1 or type 2 diabetes for two years. Researchers tracked mental health issues like depression, anxiety, and eating problems alongside daily blood sugar levels using smartphone surveys and continuous glucose monitors. The goal was to identify patterns and subtypes to help develop personalized treatments for mental health in diabetes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,290 people

The number who actually took part.

Started

May 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

People with Type 1 Diabetes or Type 2 Diabetes

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 80 years * Diagnosis of type 1 diabetes (T1D) or type 2 diabetes (T2D) * Diabetes duration ≥ 1 year * Sufficient German language skills * Written informed consent Exclusion Criteria: * Inability to consent, * Significant cognitive impairment (e.g., cognitive disorder, dementia) * Severe somatic disease or mental disorder likely to impede study participation or confound results (e.g., severe heart failure ≥ NYHA III; cancer requiring treatment; dialysis-dependent nephropathy; schizophrenia/psychotic disorder) * Terminal illness * Being bedridden

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety and fear are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression depressive disorder diabetes mellitus eating disorder Feeding and Eating Disorders Feeding Behavior hyperglycemia type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety and fear Anxiety disorders Depressive disorder Depressive symptoms Diabetes mellitus Eating behavior Eating disorder symptom Eating disorders Emotional distress Hyperglycemia

Contacts and locations

Locations

  • Diabetes Center Mergentheim

    Bad Mergentheim, Baden-Wurttemberg, 97980, Germany

  • Diabetes Practice Mergentheim

    Bad Mergentheim, Baden-Wurttemberg, 97980, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.